✦ LIBER ✦

CN3: AN ECONOMIC MODEL FOR THE PHARMACOLOGICAL MANAGEMENT OF ADVANCED NON-SMALL CELL LUNG CANCER IN THE US

✍ Scribed by SV Sorensen; M Chambers; A Heyes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

US guidelines published for the manageme

✍ Dorothy Bonn 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 72 KB

Docetaxel (Taxotere®) in the management

✍ Miller, Vincent A. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 133 KB

CN3 THE VALUE OF RESEARCH FOR ERCC1 TEST

✍ J. Roth; J.J. Carlson; L. Steuten; D. Veenstra 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

The management of PS2 patients with adva

✍ K. A. CHEONG; K. CHRYSTAL; P. G. HARPER 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Management of the elderly patient with a

✍ K. A. Cheong; K. Chrystal; P. G. Harper 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

31 The use of pemetrexed in advanced non

✍ Ng, C.; Harris, M.A.; Burt, P.A.; Sheikh, H.S.; Lee, L.; Blackhall, F.H.; Summer 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 48 KB